Company Overview of Chronix Biomedical, Inc.
Chronix Biomedical, Inc., a molecular diagnostic company, develops DNA-based blood tests primarily for monitoring minimal residual disease (MRD) in cancer patients. It offers a breast cancer neoadjuvant companion diagnostic test that enables physicians to determine whether cancer remains in the body post chemotherapy; and develops a technology that measures personalized biomarkers in cancers of the colorectum, prostate, lung, ovarian, pancreas, blood, and central nervous system. The company was founded in 1997 and is based in San Jose, California. It has laboratories in Göttingen, Germany; and Brookings, South Dakota.
5941 Optical Court
San Jose, CA 95138
Founded in 1997
Key Executives for Chronix Biomedical, Inc.
Chronix Biomedical, Inc. Key Developments
Similar Private Companies By Industry
|Immunovative Clinical Research, Inc.||United States|
|Impel Neuropharma Inc.||United States|
|ProdiGene, Inc.||United States|
|RGene Therapeutics, Inc.||United States|
|Southern Biosystems, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Chronix Biomedical, Inc., please visit www.chronixbiomedical.com. Company data is provided by Capital IQ. Please use this form to report any data issues.